Galnac Lipid I-1 Datasheet DC Chemicals

Description	Disclosed in PCT patent WO2025/240833A1 from Acuitas Therapeutics Inc., Compound I‑1 is a trivalent tri-GalNAc PEGylated targeting lipid composed of three ASGPR-binding GalNAc moieties, a PEG spacer and double C18 alkyl lipid tails that insert into LNP lipid bilayer.
Cat.No	DC68164
Name	Galnac Lipid I-1

Chemical Properties

CAS
Formula
MW
Storage	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

References

Return Policy

If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.

Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.

Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com